PTC Therapeutics Inc. (PTCT) Insider, 13F Hedge Fund & Politician Buy/Sell Thermometer
PTC Therapeutics Inc. (PTCT) earns a Roarable Rating of B- (Buy) with 70/100 RQD Confidence. High-quality cash engine (41% profit margin, 85% return on capital) with steady institutional support. Even if the broader market gets choppy, the companyβs underlying cash engine and big-money support put the odds in buyersβ favor.
PTCT Smart-Money Thermometer: BALANCED INSTITUTIONAL POSITIONING
Wide-Open SEC Form 4, 13F & Congressional Disclosure Ledger (PTCT)
No recent open-market Form 4 cluster sales or emergency dumps flagged on PTCT. Visit the Global 13F & Congressional Whale Ledger for cross-market smart-money filings.
Today's Top 3 RQD Strong Buys & Whale Accumulation Setups (Live PTCT Tape Review)
- βLive breakdown of todayβs highest-scoring RQD Green-Light breakouts
- β1 urgent Red-Light accounting trap to cut from your watchlist immediately
- βBring any ticker to live Q&Aβwe run it through the 5-Pillar RQD Radar on screen
PTCT Dilution Monitor, Expectations Hurdle, Butterfly Connections & Policy Exposure
Multi-year comparable XBRL diluted share count not disclosed (ETF or recent listing).
vs. +114.5% actual YoY revenue growth (assuming 9.25% cost of equity & 16.5x terminal multiple).
No active Ellis Vennor swing setup published on PTCT today. View full Setup Ledger β
No direct multi-tier Butterfly edges indexed yet for PTCT. Explore sector supply chains on /butterfly.
PTCT Investor FAQ & Complete 8-Part Research Index
100% OPEN ACCESS β’ SEC EDGAR Γ CBOE Γ FREDAre PTCT insiders and hedge funds buying or selling?
Roarable's SEC Form 4 and 13F Whale Thermometer currently classifies PTCT leadership and institutional positioning as: BALANCED INSTITUTIONAL POSITIONING.